David Henry Mack is CEO & President at PMV Pharmaceuticals, Inc. (PMVP). They have made 4 open-market trades across 2 companies since 2011, most recently 2025-10-27.
CIK 0001341642
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $3.4M since 2011, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PMVP | SELL | 2025-07-01 | 2025-07-03 | $1.06 | $124K | +15.5% | +24.1% | +17.2% |
| PMVP | SELL | 2021-07-20 | 2021-07-22 | $35.76 | $2.0M | -0.5% | -10.2% | -31.5% |
| PMVP | SELL · 10b5-1 | 2021-06-28 | 2021-06-29 | $35.53 | $7K | +3.6% | +3.4% | -12.5% |
| PMVP | SELL | 2021-05-20 | 2021-05-24 | $35.65 | $998K | -7.1% | -13.2% | -14.5% |
| ACRX | BUY | 2011-02-16 | 2011-02-18 | $5.00 | $3.4M | -21.8% | -0.4% | -0.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.